Formulation Change for Erenumabix. Labeling Change for Erenumabix — critical change. Impacts 4 markets and 1 variations.

Change Number
CHG-2021-0080
Type
Formulation Change
Product
Status
Approved
Owner
Marcus Webb
Initiated
2023-07-28
Description

Labeling Change for Erenumabix — critical change

Impacted Markets (4)
CN — ChinaGB — United KingdomIN — IndiaTR — Turkey
Impacted Modules
4.2.13.2.P2.3.P
Linked Variations (1)
Variation #TypeApplicationStatusSubmittedApproved
TITCK-2024-0096-V396Type IITITCK-2024-0096Completed2024-02-15—